GB2303550A - Colonic drug delivery composition - Google Patents
Colonic drug delivery compositionInfo
- Publication number
- GB2303550A GB2303550A GB9626012A GB9626012A GB2303550A GB 2303550 A GB2303550 A GB 2303550A GB 9626012 A GB9626012 A GB 9626012A GB 9626012 A GB9626012 A GB 9626012A GB 2303550 A GB2303550 A GB 2303550A
- Authority
- GB
- United Kingdom
- Prior art keywords
- colon
- drug
- delivery composition
- drug delivery
- colonic drug
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4891—Coated capsules; Multilayered drug free capsule shells
Landscapes
- Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
Abstract
A colonic drag delivery composition is provided and comprises a starch capsule containing a drug, the starch capsule being provided with a coating such that the drug will only be released from the capsule in the colon. The coating may be a pH-sensitive material, a redox-sensitive material or a material broken dawn by specific enzymes or bacteria present in the colon. The drug to be delivered may be one for local action in the colon, or a systemically active drug to be absorbed from the colon.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9626012A GB2303550B (en) | 1994-06-21 | 1995-06-21 | Colonic drug delivery system |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9412394A GB9412394D0 (en) | 1994-06-21 | 1994-06-21 | Colonic drug delivery composition |
PCT/GB1995/001458 WO1995035100A1 (en) | 1994-06-21 | 1995-06-21 | Colonic drug delivery composition |
GB9626012A GB2303550B (en) | 1994-06-21 | 1995-06-21 | Colonic drug delivery system |
Publications (3)
Publication Number | Publication Date |
---|---|
GB9626012D0 GB9626012D0 (en) | 1997-01-29 |
GB2303550A true GB2303550A (en) | 1997-02-26 |
GB2303550B GB2303550B (en) | 1998-07-08 |
Family
ID=26305091
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB9626012A Revoked GB2303550B (en) | 1994-06-21 | 1995-06-21 | Colonic drug delivery system |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB2303550B (en) |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1983000435A1 (en) * | 1981-07-31 | 1983-02-17 | Rhodes, John | Orally administrable pharmaceutical compositions |
EP0225189A2 (en) * | 1985-11-29 | 1987-06-10 | R.P. Scherer Corporation | Targeted enteral delivery system |
DE8715583U1 (en) * | 1987-11-24 | 1988-01-28 | Greither, Peter, Kirchberg | capsule |
EP0313845A1 (en) * | 1987-09-29 | 1989-05-03 | Warner-Lambert Company | Stabilization of enteric coated dosage form |
EP0317510A2 (en) * | 1987-11-20 | 1989-05-24 | Greither, Peter | Capsule and its method of manufacturing |
EP0420459A2 (en) * | 1989-09-27 | 1991-04-03 | Warner-Lambert Company | Oral pharmaceutical composition for acid sensitive proteinaceous agents |
WO1991011175A1 (en) * | 1990-01-29 | 1991-08-08 | Danbiosyst Uk Ltd | Process for the preparation of azo- and/or disulfide-containing polymers |
WO1995006464A1 (en) * | 1993-09-01 | 1995-03-09 | Sandoz Ltd | Pharmaceutical preparations for the targeted treatment of morbus crohn and colitis ulcerosa |
-
1995
- 1995-06-21 GB GB9626012A patent/GB2303550B/en not_active Revoked
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1983000435A1 (en) * | 1981-07-31 | 1983-02-17 | Rhodes, John | Orally administrable pharmaceutical compositions |
EP0225189A2 (en) * | 1985-11-29 | 1987-06-10 | R.P. Scherer Corporation | Targeted enteral delivery system |
EP0313845A1 (en) * | 1987-09-29 | 1989-05-03 | Warner-Lambert Company | Stabilization of enteric coated dosage form |
EP0317510A2 (en) * | 1987-11-20 | 1989-05-24 | Greither, Peter | Capsule and its method of manufacturing |
DE8715583U1 (en) * | 1987-11-24 | 1988-01-28 | Greither, Peter, Kirchberg | capsule |
EP0420459A2 (en) * | 1989-09-27 | 1991-04-03 | Warner-Lambert Company | Oral pharmaceutical composition for acid sensitive proteinaceous agents |
WO1991011175A1 (en) * | 1990-01-29 | 1991-08-08 | Danbiosyst Uk Ltd | Process for the preparation of azo- and/or disulfide-containing polymers |
WO1995006464A1 (en) * | 1993-09-01 | 1995-03-09 | Sandoz Ltd | Pharmaceutical preparations for the targeted treatment of morbus crohn and colitis ulcerosa |
Also Published As
Publication number | Publication date |
---|---|
GB9626012D0 (en) | 1997-01-29 |
GB2303550B (en) | 1998-07-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2193481A1 (en) | Colonic drug delivery composition | |
PT1006935E (en) | HIGH VISCOSITY LIQUID CONTROLLED DELIVERY SYSTEM | |
CA2395331A1 (en) | Pharmaceutical compositions providing enhanced drug concentrations | |
CA2188677A1 (en) | Drug delivery device and method of construction | |
EA200401086A1 (en) | COATED CHEWING GUM, CONTAINING ACTIVE SUBSTANCE OF SYSTEMIC ACTION | |
AU6027096A (en) | Delivery of oxygen-supersaturated physiologic solutions | |
MX9803593A (en) | Absorbent article having a cellulosic transfer layer. | |
ZA963392B (en) | Triggered active packagig material | |
MY134742A (en) | Delivery device having encapsulated excipients | |
NZ514248A (en) | Pharmaceutical composition in a unit form containing acetylsalcylic acid and clopidogrel hydrogenosulphate | |
USD278599S (en) | Bottle | |
BR9815315A (en) | Applicator system | |
AU5655696A (en) | Pharmaceutical composition containing acetylcysteine, carboc ysteine or erdosteine in combination with a beta 2 agonist a nd an expectorant for the treatment of respiratory tract dis orders | |
GB2303550A (en) | Colonic drug delivery composition | |
ES2136969T3 (en) | METHOD AND COMPOSITION TO PROVIDE A BARRIER LINING TO HUMID VAPORS AND SUITABLE TO BE REDUCED AGAIN TO PAPER MILL, FOR FLEXIBLE PACKAGING. | |
EP0666292A3 (en) | Coating composition and coating film composition. | |
CA2185242A1 (en) | Sustained release tablet containing diclofenac-na | |
MY117808A (en) | Cancer cell nuclease activator | |
AU668767B2 (en) | Oral medicament form | |
AU5785096A (en) | Bleaching of cellulose pulp in one and the same stage with a complexing agent, a molybdenum containing substance and an oxidative bleaching agent | |
DE59607949D1 (en) | SOLID MEDICINAL FORM WITH POLYMER MATERIAL DISTRIBUTED ACTIVE SUBSTANCE | |
GB9407589D0 (en) | Container | |
EP0679391A3 (en) | Solid pharmaceutical dosage form containing flavored film coating. | |
CA2007764A1 (en) | Salsalate tablet | |
TW349987B (en) | Starch-based glueing agent and paper coating composition containing the same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
773K | Patent revoked under sect. 73(2)/1977 |